Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avian Flu”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Testing effectiveness (Phase 2)Study completedNCT04789577
What this trial is testing

Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

Who this might be right for
Influenza, Human
GlaxoSmithKline 833
Testing effectiveness (Phase 2)Study completedNCT03312231
What this trial is testing

Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 720
Early research (Phase 1)Study completedNCT00709800
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle)

Who this might be right for
Influenza
Vical 56
Early research (Phase 1)Study completedNCT00694213
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)

Who this might be right for
Influenza
Vical 47
Early research (Phase 1)Study completedNCT03345043
What this trial is testing

Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

Who this might be right for
Influenza
ModernaTX, Inc. 156
Testing effectiveness (Phase 2)Study completedNCT02153671
What this trial is testing

Immunogenicity of H5N1 Vaccine Following H5N2

Who this might be right for
Influenza Vaccine
PATH 43
Early research (Phase 1)Study completedNCT02335164
What this trial is testing

Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Who this might be right for
Influenza
Vaxine Pty Ltd 270
Testing effectiveness (Phase 2)WithdrawnNCT01037634
What this trial is testing

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00517517
What this trial is testing

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 110
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT01416571
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 78
Testing effectiveness (Phase 2)Study completedNCT00620815
What this trial is testing

Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
Novartis Vaccines 601
Early research (Phase 1)Study completedNCT01184976
What this trial is testing

Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males

Who this might be right for
Healthy
GeneOne Life Science, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02229357
What this trial is testing

Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine

Who this might be right for
Avian Influenza
Mahidol University 60
Early research (Phase 1)Study completedNCT01657929
What this trial is testing

H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Influenza A Subtype H5N1 Infection
Access to Advanced Health Institute (AAHI) 105
Early research (Phase 1)Study completedNCT02274545
What this trial is testing

Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT01443936
What this trial is testing

Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 96
Testing effectiveness (Phase 2)Study completedNCT00133536
What this trial is testing

A/H5N1 Vaccine in Healthy Children Aged 2-9 Years

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 157
Early research (Phase 1)Study completedNCT01443663
What this trial is testing

Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine

Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 69
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation